de Luise M - Search Results

1

Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.

Zalcberg JR, Hu XF, Ching M, Wakeling A, Wall DM, Marschner IC, de Luise M. Zalcberg JR, et al. Among authors: de luise m. Cancer Chemother Pharmacol. 1993;33(2):123-9. doi: 10.1007/BF00685329. Cancer Chemother Pharmacol. 1993. PMID: 7903222

2

Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384.

Hu XF, Nadalin G, De Luise M, Martin TJ, Wakeling A, Huggins R, Zalcberg JR. Hu XF, et al. Among authors: de luise m. Eur J Cancer. 1991;27(6):773-7. doi: 10.1016/0277-5379(91)90187-i. Eur J Cancer. 1991. PMID: 1648945

3

Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.

Hu XF, Martin TJ, Bell DR, de Luise M, Zalcberg JR. Hu XF, et al. Among authors: de luise m. Cancer Res. 1990 May 15;50(10):2953-7. Cancer Res. 1990. PMID: 2334897

4

Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.

Zalcberg JR, Hu XF, Wall DM, Mirski S, Cole S, Nadalin G, De Luise M, Parkin JD, Vrazas V, Campbell L, et al. Zalcberg JR, et al. Among authors: de luise m. Int J Cancer. 1994 May 15;57(4):522-8. doi: 10.1002/ijc.2910570414. Int J Cancer. 1994. PMID: 7514153

5

The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor.

Parisot JP, Hu XF, Sutherland RL, Wakeling A, Zalcberg JR, DeLuise M. Parisot JP, et al. Int J Cancer. 1995 Aug 9;62(4):480-4. doi: 10.1002/ijc.2910620420. Int J Cancer. 1995. PMID: 7635575

6

Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.

Hu XF, Veroni M, De Luise M, Wakeling A, Sutherland R, Watts CK, Zalcberg JR. Hu XF, et al. Among authors: de luise m. Int J Cancer. 1993 Nov 11;55(5):873-6. doi: 10.1002/ijc.2910550529. Int J Cancer. 1993. PMID: 8244585

7

Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.

Parisot JP, Leeding KS, Hu XF, DeLuise M, Zalcberg JR, Bach LA. Parisot JP, et al. Breast Cancer Res Treat. 1999 Jun;55(3):231-42. doi: 10.1023/a:1006274712664. Breast Cancer Res Treat. 1999. PMID: 10517168

8

Effect of cyclosporin and verapamil on the cellular kinetics of daunorubicin.

Hu XF, de Luise M, Martin TJ, Zalcberg JR. Hu XF, et al. Among authors: de luise m. Eur J Cancer. 1990;26(7):814-7. doi: 10.1016/0277-5379(90)90159-q. Eur J Cancer. 1990. PMID: 2145901

9

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.

Parisot JP, Hu XF, DeLuise M, Zalcberg JR. Parisot JP, et al. Br J Cancer. 1999 Feb;79(5-6):693-700. doi: 10.1038/sj.bjc.6690112. Br J Cancer. 1999. PMID: 10070856 Free PMC article.

10

Insulin stimulation of Na+-K+ pump in clonal rat osteosarcoma cells.

De Luise MA, Harker M. De Luise MA, et al. Diabetes. 1988 Jan;37(1):33-7. doi: 10.2337/diab.37.1.33. Diabetes. 1988. PMID: 2446938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters